Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2084
|
288
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.010 |
None |
< 0.001 |
1 |
|
2006 |
2006 |
Therapy-related myelodysplastic syndrome
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
42
|
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2004 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2019 |
Childhood Acute Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
215
|
6
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2010 |
Acute biphenotypic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
45
|
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2007 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Developmental delay (disorder)
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
584
|
68
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Mixed phenotype acute leukemia
|
disease |
|
Neoplastic Process
|
37
|
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2007 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2012 |
Neurodevelopmental Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
535
|
14
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Childhood Acute Monocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2001 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2018 |
Adult Acute Monocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
70
|
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2001 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
|
2004 |
2018 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.040 |
None |
0.750 |
4 |
|
1998 |
2016 |
Erythrophagocytosis
|
disease |
|
Disease or Syndrome
|
40
|
|
0.050 |
None |
0.800 |
5 |
|
1998 |
2014 |
Monocytic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
71
|
|
0.050 |
None |
1.000 |
5 |
|
2001 |
2014 |
Acute myelomonocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
105
|
3
|
0.050 |
None |
0.800 |
5 |
|
2001 |
2010 |
M5b Acute differentiated monocytic leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
122
|
|
0.060 |
None |
1.000 |
6 |
|
1998 |
2014 |